Update on Middle Eastern Respiratory Syndrome {#s1}
=============================================

(Prepared by the section editor)---The coronavirus of Middle Eastern respiratory syndrome (MERS) has caused respiratory illnesses in the Middle East since it was first identified in mid-2012. As of 28 August 2017, there have been 2067 cases of MERS reported to the World Health Organization, including at least 720 deaths (case fatality rate of 34.8%). Cases have been reported from 27 countries, all with the index case originating in the Middle East, with 82% of cases having been reported by Saudi Arabia. The number of deaths to date (720) is close to the 724 deaths that occurred in the severe acute respiratory syndrome outbreak of 2002--2003.

In the 1-year period from 1 July 2016 to 30 June 2017, 251 cases of MERS were reported, of which 243 (97%) were reported from Saudi Arabia, 3 from Qatar, 2 from the United Arab Emirates, and 1 each from Oman, Austria (with travel from Saudi Arabia), and Thailand (with travel from Kuwait). Thirty-seven (15%) of the 243 Saudi Arabia cases were asymptomatic contacts of known MERS cases. Of the 243 cases reported by Saudi Arabia in this period, 67 (28%) involved nosocomial transmission, mainly in healthcare workers (60%); 14 (6%) involved household contact; 74 (30%) were related to camel or camel product contact; and the largest group of 84 (35%) had no apparent risk factors.

The MERS virus has been found in camels throughout Africa including Egypt where more than 90% of camels have serological evidence of past infection. However, serological studies have not demonstrated evidence of antibodies in any of the humans who had close contact with these camels.

It is a mystery as to why Saudi Arabia is the epicenter of MERS compared to other Middle Eastern countries or why it has not occurred (to my knowledge) in African countries. The main hypothesis that has been given is that unrecognized cases occur in these countries or that the coronavirus is less virulent in these countries. However, the Egyptians have detected cases of avian influenza, and it is a stretch to think that they are unable to suspect and detect the coronavirus of MERS. Furthermore, at least 1 isolate from an Egyptian camel was genetically very similar to a MERS coronavirus that is infecting humans.

There is also no solid information as to the source of MERS in 35% of cases that occurred in Saudi Arabia in the year as described above. Inadequate histories probably play a role. In addition, 1 small study demonstrated that any contact with other individuals who had direct contact with camels might play a role in transmission.

Kedrion Biopharma and Kamada Receive USFDA Approval of KEDRAB {#s2}
=============================================================

25 August 2017 (Globe Newswire)---Kedrion Biopharma and Kamada Ltd., 2 leading human-derived protein therapeutics companies, announced that Kedrab (rabies immune globulin \[human\]) has received US Food and Drug Administration (FDA) approval for passive, transient post-exposure prophylaxis of rabies infection, when given immediately after contact with a rabid or possibly rabid animal. Rabies impacts approximately 40,000 people in the United States each year.

Prior to the FDA approval, US healthcare professionals had only 2 human rabies immune globulin therapy options from which to choose to prevent the onset of rabies in someone who may have been exposed to the deadly virus. Kedrab, a human plasma--derived (high titer) immunoglobulin, is entering a rabies market that has experienced inconsistent supply in recent years. Kamada has been selling the human rabies immune globulin product since 2006 in numerous territories outside of the United States under the brand name KamRAB. Kamada has sold more than 1.4 million vials of KamRAB to date, demonstrating significant clinical experience with the product.

Philippines Watching Suspected Bird Flu Cases in Humans {#s3}
=======================================================

25 August 2017 (Reuters \[Manuel Mogato, Martin Petty, and Christian Schmollinger\])---The Philippines started monitoring suspected bird flu cases in humans on 25 August 2017 after 34 farm workers in 2 towns north of the capital, Manila, developed flu-like symptoms after direct exposure to infected fowl.

Officials from the Departments of Health and Agriculture said laboratory tests in Australia confirmed an outbreak of the deadly H5N6 strain of the bird flu virus. The strain is transmissible to humans, but the mortality rate is low.

Health Minister Paulyn Ubial told a news conference about the 34 suspected cases of bird flu infection. "They developed fever, cough and cold," she said, adding that some had diarrhea. "All of them had direct exposure to fowls, and they developed common symptoms of influenza. They were already given medicines, but we are now monitoring their conditions."

The Philippines has culled more than 470 000 chickens, ducks, and quail in 3 towns in Pampanga and Nueva Ecija since 11 August, a day after the government confirmed the first bird flu outbreak in the country.
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***Editorial comment:*** Outbreaks of avian influenza A(H5N6) with high pathogenicity for poultry have been widespread in China, South Korea, Japan, Myanmar, Laos, and Vietnam since 2014. It is not easily spread to humans, and most cases have been mild. A total of 6 to 20 deaths have been reported according to different sources, all apparently in China.

Fatal Pneumonic Tularemia Associated with Dog Exposure---Arizona, June 2016 {#s4}
===========================================================================

(MMWR 66:891, 2017)---On 15 June 2016, Arizona public health officials were notified of a presumptive positive *Francisella tularensis* blood culture result from a woman aged 73 years with pulmonary sarcoidosis who had recently died from respiratory failure. She was evaluated on 6 June after experiencing 4 days of fever, myalgia, anorexia, and diarrhea. Two days later, she was hospitalized for shortness of breath and confusion. Chest radiography revealed a right lower lobe pneumonia and an effusion. This was treated with cefepime and intravenous doxycycline. On 8 June, her stool tested positive for *Clostridium difficile* toxin A/B by polymerase chain reaction, requiring treatment with metronidazole and vancomycin. She died on 11 June. A blood culture collected on 6 June was confirmed as *F. tularensis*, a tier 1 select agent.

The patient lived in a semirural area of northern Arizona, did not engage in outdoor activities, and had no known history of insect bites or exposure to animal carcasses or untreated water. She had traveled to Hawaii 16--26 May and returned approximately 11 days before illness onset. Post-mortem exam revealed no bites, abscesses, or lymphadenopathy.

The patient's dog was noted to be lethargic and anorexic in late May, 3 days after being found with a rabbit carcass in its mouth. Serum from the dog, obtained approximately 3 weeks after its illness and the patient's death, had a *F. tularensis*--specific titer of 1:256. An assessment of the property on 23 June revealed numerous rabbits and 1 squirrel carcass with *F*. *tularensis* DNA detected in the liver and spleen. Genotyping of *F. tularensis* from squirrel and human samples showed that both infections were attributable to an A.II strain.

Approximately 125 human tularemia cases are reported in the United States annually. Humans are infected through arthropod bites, contact with infectious tissues, inhalation, or ingestion. Symptoms commonly begin 3--5 days after exposure and can include fever, skin lesions, lymphadenopathy, difficulty breathing, and diarrhea.

Two *F. tularensis* subspecies, *tularensis* (type A) and *holarctica* (type B), cause human tularemia. Distinct clades within type A (A.I and A.II) are associated with different virulence in humans and laboratory animals. A.II strains are localized to the western United States and associated with milder illness than are A.I strains.

Exposure likely occurred at the woman's property through inhalation of *F. tularensis*, potentially via close contact with her dog. The dog might have transmitted infectious material through oral secretions after mouthing an infected carcass or might have brought infectious material on its fur into contact with the patient. Human illness linked to dogs has been documented.

The role of pulmonary sarcoidosis in this patient's illness is unclear, but it might have contributed to the severe outcome of infection with an A.II strain.

***Editorial comment***: Human illness has been transmitted from a dog in at least 1 previous report, where a dog shaking itself apparently aerosolized *F. tularensis* and infected 15 people, all of whom developed mainly pulmonary disease.

Of interest are 2 outbreaks of pneumonic tularemia that occurred on Martha's Vineyard in 1978 and 2000. The risk factors for these outbreaks were mowing lawns and cutting brush. It has been speculated that the disease occurred from inhalation of aerosolized *F. tularensis* resulting from the mower going over rabbits' nests.
